Amino acid link to diabetes

Genetic differences in amino acid metabolism are linked to an increased risk of type 2 diabetes, British researchers have reported.

The findings could mean the development of therapies aimed at tackling the break-down of branched chain amino acids and reduce the risk of disease, the researchers said.

The findings come from a study that began with more than 10 million genetic variants in 16,000 volunteers at Cambridge University.

Reporting in PLoS Medicine, they say they found five genetic variants linked to high levels of the branched chain amino acids, isoleucine, leucine and valine.

Further analysis in 300,000 people, including 40,000 with diabetes, found that the genetic variants were also linked to an increased risk of developing type 2 diabetes.

The most strongly linked gene was PPM1K, which plays a key role in the break-down of branched chain amino acids.

Researcher Dr Claudia Langenberg said: “Our results suggest that treatment strategies which target metabolism of branched-chain amino acids could help to reduce the risk of diabetes, and we already know which molecules target this metabolic pathway.”

Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis. Luca Lotta et al. PLOS Medicine 21 November 2016 [abstract]

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index